整顿 发表于 2025-3-28 16:42:05

https://doi.org/10.1007/978-3-031-47630-3 Approximately 25–50% of these patients may enjoy long-term disease-free survival (DFS), and current research efforts are focused on innovative postremission strategies with the goal of improving the overall survival for adults with ALL. The identification of different prognostic groups based on the

好开玩笑 发表于 2025-3-28 20:28:16

http://reply.papertrans.cn/16/1539/153834/153834_42.png

沟通 发表于 2025-3-28 22:53:57

http://reply.papertrans.cn/16/1539/153834/153834_43.png

碎石头 发表于 2025-3-29 04:10:56

http://reply.papertrans.cn/16/1539/153834/153834_44.png

Muscularis 发表于 2025-3-29 07:33:03

https://doi.org/10.1007/978-981-99-9987-3 NHL, which makes it the fifth leading cause of cancer death in men and the sixth leading cause of cancer death among women .. NHLs represent around 5% of all newly diagnosed cancers and, in contrast with other malignancies that are decreasing in incidence, the overall incidence of NHL has been incr

Fibrinogen 发表于 2025-3-29 15:09:35

http://reply.papertrans.cn/16/1539/153834/153834_46.png

联合 发表于 2025-3-29 17:26:56

https://doi.org/10.1007/978-3-319-90335-4lood (PB) have been successfully utilized in the treatment of high risk or recurrent hematological malignancies, BM failure syndromes, hemoglobinopathies, selected hereditary immunodeficiency states, and inborn errrors of metabolism .. However, a number of limitations exist that impede the successfu

aggressor 发表于 2025-3-29 22:42:00

http://reply.papertrans.cn/16/1539/153834/153834_48.png

tolerance 发表于 2025-3-30 00:07:21

http://reply.papertrans.cn/16/1539/153834/153834_49.png

Cpr951 发表于 2025-3-30 04:48:27

R. K. Silbereisen,P. Noack,K. Eyferthicant potential benefits for the treatment of multiple types of illnesses, as outlined throughout this text. Unfortunately, the majority of patients are not candidates for this approach. This chapter will discuss a shift in the understanding of the requirements for successful allogeneic hematopoieti
页: 1 2 3 4 [5] 6
查看完整版本: Titlebook: Allogeneic Stem Cell Transplantation; Mary J. Laughlin,Hillard M. Lazarus Book 20031st edition Humana Press 2003 Grading.T cell.blood.cell